NEUROLEPTIC MALIGNANT SYNDROME AND HYPOTHYROIDISM

被引:10
作者
MOORE, AP
MACFARLANE, IA
BLUMHARDT, LD
机构
[1] Dept. of Neurological Science, Walton Hospital, Liverpool L9 1AE, Rice Lane
关键词
D O I
10.1136/jnnp.53.6.517
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Two patients with primary hypothyroidism who developed neuroleptic malignant syndrome (NMS) are described. Thyroid disease might predispose to NMS by altering brain dopamine metabolism.
引用
收藏
页码:517 / 518
页数:2
相关论文
共 7 条
[1]  
CAROFF SN, 1980, J CLIN PSYCHIAT, V41, P79
[2]  
FISHMAN RA, 1988, OXFORD TXB MED
[3]   THYROTROPIN REGULATES THYROTROPH RESPONSIVENESS TO DOPAMINE INVITRO [J].
FOORD, SM ;
PETERS, JR ;
DIEGUEZ, C ;
SHEWRING, G ;
HALL, R ;
SCANLON, MF .
ENDOCRINOLOGY, 1986, 118 (04) :1319-1326
[4]   MODULATION OF DOPAMINE-RECEPTORS BY THYROTROPIN-RELEASING-HORMONE IN THE RAT-BRAIN [J].
FUNATSU, KS ;
INANAGA, K .
PEPTIDES, 1987, 8 (02) :319-325
[5]   CURRENT CONCEPTS - NEUROLEPTIC MALIGNANT SYNDROME [J].
GUZE, BH ;
BAXTER, LR .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (03) :163-166
[6]  
LIM R, 1989, BRIT J HOSP MED, V41, P182
[7]   THE SECRETORY ACTIVITY OF THE TUBEROINFUNDIBULAR DOPAMINERGIC-NEURONS IS MODULATED BY THE THYROID STATUS IN THE ADULT-RAT - CONSEQUENCE ON PROLACTIN SECRETION [J].
REYMOND, MJ ;
BENOTTO, W ;
LEMARCHANDBERAUD, T .
NEUROENDOCRINOLOGY, 1987, 46 (01) :62-68